News

Damage to brain’s white matter may play key role in neurodegenerative disease, and could be target for future treatments

22 April 2026

Damage to white matter in the brain can trigger features associated with neurodegenerative disease, Cambridge researchers have discovered in a new study published today in the journal Nature . Until now, it was thought that neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease were primarily associated...

Research from Rowitch and collaborators uncovers vulnerable brain cells prone to DNA damage in development and Multiple Sclerosis (MS)

2 April 2026

A multi-centre team of investigators have identified critical neurons in the grey matter, the “thinking” portion of the brain, that are especially prone to DNA damage as neurological disease-related inflammation progresses. The findings, stemming from two complementary studies published this week in Nature , could lead to...

Alcolea Group discovery on tumour development could help catch and treat cancer at earliest stages

4 March 2026

Scientists from the Alcolea Group at the Cambridge Stem Cell Institute and collaborators at PDN have shown that when tumours first emerge, interactions with healthy cells in the underlying supportive tissue determine their ability to survive, grow, and progress to advanced stages of disease. The study, carried out in mice...

Image in a lab of a microscope and blood samples

Hodson Group develops 'liquid biopsy' test to predict treatment response in patients with aggressive blood cancer

22 January 2026

The Hodson Group and collaborators have developed a customised blood test that can predict, more accurately than standard scans, whether treatment has successfully eradicated diffuse large B-cell lymphoma (DLBCL). DLBCL is the most common form of aggressive non-Hodgkin lymphoma, and is typically treated with a combination...

CSCI's Teichmann Lab and GSK announce new partnership to advance our understanding of the role of cells and tissues in disease, paving the way for new medical breakthroughs

13 January 2026

The collaboration, announced last month, will use state-of-the-art genomics approaches in combination with machine learning methods to advance our scientific understanding of cells and tissues in health and disease. GSK is investing nearly £10 million in this ground-breaking alliance that brings together the expertise of...

CSCI celebrates fourth annual Christmas Market at JCBC!

8 December 2025

On Friday 5 December, CSCI celebrated our fourth annual Christmas Market at the Jeffrey Cheah Biomedical Centre . Partnering with our neighbours at Cancer Research UK Cambridge Institute , Cambridge Biomedical Campus , The Milner Therapeutics Institute , and Cambridge Institute of Therapeutic Immunology & Infectious...

CSCI’s Professor Sarah Teichmann elected to the US National Academy of Medicine

21 October 2025

Professor Sarah Teichmann (Chair in Stem Cell Medicine, Cambridge Stem Cell Institute, Department of Medicine, University of Cambridge) has been elected to the prestigious National Academy of Medicine in the USA. She was announced as one of 90 new regular members and 10 new international members during the annual meeting...

Bertie Göttgens joins Stem Cell Reports as a new Editorial Board member

3 October 2025

Stem Cell Reports , the official journal of the International Society for Stem Cell Research, has just welcomed Cambridge Stem Cell Institute Director Bertie Göttgens as one of 13 new distinguished researchers to the Editorial Board. The new appointments are designed to broaden representation across the international...

New research uncovers link between telomere shortening and age-related blood mutations driving leukaemia

29 August 2025

A groundbreaking study led by Professor George Vassiliou at the Cambridge Stem Cell Institute and University of Cambridge has revealed that age-related telomere shortening plays a key role in the development of clonal haematopoiesis (CH) and blood cancers driven by mutations in RNA splicing genes. The findings, published...

Watch our new Institute video now! A Place of Possibility

15 July 2025

We are very excited to launch our new institute video, A Place of Possibility / Cambridge Stem Cell Institute, showcasing some of the people that form our research community. Watch this three-minute video to hear from our students, postdocs, facilities team, admin team, and Director as they demonstrate how the...